Ombitasvir | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Ombitasvir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 PMC Isochem, 1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

2 Emulsifying Agents, 1 Topical, 1 Thickeners and Stabilizers, 1 Film Formers & Plasticizers, 1 Solubilizers

DIGITAL CONTENT

30 NEWS #PharmaBuzz

30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

3 Annual Reports

PATENTS & EXCLUSIVITIES

27 US Patents

27 US Patents

Xls

Filters

Filters

FILTER :

filter Product Reset all filters

3 All

01 2Viekira

02 1Viekira Pak

List of Suppliers

Product Main Page

01

Brand Name : Viekira Pak

Pittcon 2025

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ombitasvir/Paritaprevir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 1,522

2015 Revenue in Millions : 1,639

Growth (%) : -7

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Viekira

Pittcon 2025

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ombitasvir/Paritaprevir/Ritonavir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 178

2017 Revenue in Millions : 0

Growth (%) : New Launch

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Viekira

Pittcon 2025

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 36

2018 Revenue in Millions : 178

Growth (%) : -80

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info